Weight Loss protocols

AICAR dosing and reconstitution protocol — the AMPK-activating research compound for metabolic and endurance protocols.

Comprehensive dosing protocol for Retatrutide including reconstitution, titration schedule, cycle management, and safety considerations.

Adipotide dosing protocol — the pro-apoptotic peptide that targets the blood vessels feeding white fat tissue, cutting off the depot's supply line.

Semaglutide dosing protocol covering all vial sizes, titration schedule, and cycle guidelines. The GLP-1 receptor agonist for weight management research.

Survodutide dosing protocol — the GLP-1/glucagon dual agonist titrated over 12+ weeks, boosting energy burn while titration manages side effects.

Complete dosing protocol for Tirzepatide with dual GLP-1/GIP agonism, reconstitution steps, and titration schedule.

Injectable L-Carnitine dosing protocol — the fat-transport amino acid for metabolic research. Injection bypasses carnitine's poor oral bioavailability.

AOD-9604 fat loss peptide protocol — the HGH 177-191 fragment that stimulates lipolysis without affecting blood sugar.

Cagrilintide dosing protocol — the long-acting amylin analog for appetite and weight-loss research, often paired with a GLP-1 like semaglutide.

Mazdutide dosing protocol — the dual GLP-1/glucagon agonist for weight-loss research. The glucagon arm adds energy expenditure to GLP-1 suppression.